🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED

RecruitingPhase 4Ages 1 Year - 5 YearsAllUniversity of Oklahoma
NCT05934669 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Pain in young children has been universally under-recognized due to their inability to describe or localize pain. Improvements in pharmacological interventions are necessary to optimize patient and family experience and allow for successful and efficient procedure completion. This is the first study that will compare three intranasal medications (Intranasal Midazolam, Dexmedetomidine, and Ketamine) to evaluate the length of stay after medication administration along with patient and provider satisfaction. The objective of this study is to demonstrate superior intranasal anxiolysis for pediatric laceration repairs with the shortest emergency department stay and highest patient and provider satisfaction. Based on previous studies and medication pharmacokinetics, we hypothesize that Intranasal Ketamine will have the shortest Emergency Department (ED) stay followed by Midazolam and then Dexm

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 1-5 years old * Presents to the ED for suture repair for lacerations less than or equal to 5cm in length * Parent(s)/Caregiver(s) speak English Exclusion Criteria: * Younger than 12 months of age or older than 5 years old * Suture repair needed for lacerations are greater than 5cm in length * Known allergy or adverse effect to Midazolam, Dexmedetomidine, Ketamine, or any other sedatives * Any abnormal vital signs for age, especially heart rate and blood pressure * History of Cardiac, respiratory, renal, or liver disease * Known electrolyte abnormalities * Any ocular trauma, nasal injury, nasal deformity, significant nasal congestion, abnormalities in the nasal or oral mucosa, facial deformity, or facial injury * Home medications include beta blockers or any other blood pressure lowering agents Classified American Society of Anesthesiologists III and above * Known or anticipated difficult airway * Abnormal neurological exam * Parent(s)/Caregiver(s) do not speak English
💊

What it tests

  • Intranasal Midazolam
  • Intranasal Dexmedetomidine
  • Intranasal Ketamine
📍

Where

1 site
University of Oklahoma Health Sciences Center
Oklahoma City, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy